Job Details

Research Associate

Research Associate
Accepting BioReady
Full Time

UBC - Department of Pathology

min $55,258 – mid $63,229 - max $71,200
British Columbia
Date Posted
05/12/2017 - 13:00
Closing Date
05/01/2018 - 13:00
Job Description

The Centre for Translational ‘Omics is a newly inaugurated research facility in partnership with University of British Columbia (UBC), University of Victoria (UVic), and Vancouver Island Health Authority (VIHA). The research facility is integrated in the clinical diagnostic laboratory located at Victoria General Hospital (VGH). It operates in a clinical environment with the emphasis on clinical and translational mass spectrometry. An interdisciplinary team is developing a research Mass Spectrometer platform (3 top end Mass Spectrometers –MALDI-TOF, LC-MS/MS, High resolution qTOF) along with an in-house biobank (Bio-fluid). Primary research focus lies in the clinical assay (proteins and small molecules) development and validation, workflow optimization, clinical utility assessments, and clinical implementation. The Centre also plans to provide mass spectrometry services to its surrounding partners (UVic, UBC, McGill, UofC) in the area of stroke, cancer, and gut microbiota research.


    Education & Qualifications: 
    • PhD in chemistry or biochemistry with LC-MS experience
    • Strong record in quantitative proteomics or metabolomics
    • Track record in collaboration with multidisciplinary teams
    • Experience with Sciex LCMS systems desired but not required
    • Experience with SWATH desired but not required
    Duties & Responsibilities: 

    The successful candidate will have 3-5 years hands-on experience in operating and maintaining MS instruments. The position involves developing methods for proteomic/metabolomic research, and running and implementing existing clinical methods to our MS platform. Presentation and communication of research results to a scientific audience are also required.

    Detailed duties and responsibilities include the following:

    • Operate and maintain MS instrument such as the Sciex QTrap, Sciex TripleTOF, Bruker MALDI-TOF.
    • Work with collaborators to develop identification/quantitation strategies to answer biological questions.
    • Perform method validation and quality control experiment on new MS assays
    • Analyze data and prepare scientific reports for collaborators.
    • Process MS data using vendor-specific and appropriate third-party software
    • Develop SOPs and participate in the planning and selection of new projects
    • Knowledge transfer through participating in writing research papers and the presentation of research results
    • Provide technical training to students, clinical staff and technicians     
    Other Information: 


    Benefits: Comprehensive benefits including but not limited to disability insurance, dental insurance, employee pension plan and extended medical insurance.

    Number of hours per week: 37.5 hours per week

    Duration: The anticipated start date for the position is as soon as possible, and is a 1‐year appointment with possibility of extension.

    To Apply:

    Applicants should submit complete application to Dr. Michael Chen (  

    1) Cover letter highlighting qualifications

    2) Current curriculum vitae

    3) Names and addresses of three references

    We would like to thank all applicants, however only those who qualify for an interview will be contacted.

    Equity and diversity are essential to academic excellence.  An open and diverse community fosters the inclusion of voices that have been underrepresented or discouraged.  We encourage applications from members of groups that have been marginalized on any grounds enumerated under the B.C. Human Rights Code, including sex, sexual orientation, gender identity or expression, racialization, disability, political belief, religion, marital or family status, age, and/or status as a First Nation, Metis, Inuit, or Indigenous person.

    All qualified candidates are encouraged to apply; however Canadians and permanent residents will be given priority.